Richard Jenner

Looking forward to hosting the next meeting of the London RNA Club on RNA Regulation in the Nucleus. Wednesday 25th March at UCL. Speakers including @BrockdorffLab, @Vichaico, @RobertVendramin and Folkert van Werven. eventleaf.com/e/LondonRNAClub to register.

Come join our team!! linkedin.com/posts/quezada-…

We’re excited to kick off 2026 with a joint meeting with the London RNA Club, featuring Mary Ann Allen and @stojic_lovorka! 🗓 Wednesday, February 25, 2026 ⏰ 10:00 AM MST 📍 Zoom: please RSVP here for link: docs.google.com/forms/d/e/1FAI… Supported by @RNASociety

To RNA aficionados! We are organising the @GenSocUK meeting “RNA in Physiology and Disease" in Newcastle from 7- 9 Sept. Many opportunities for short talks and an excellent line-up of speakers. More info👇 genetics.org.uk/events/rna-in-… Please share🙏

H3K79me2/3 is sufficient to antagonise PRC1 nature.com/articles/s4155…

A preprint‼️that's bound to ruffle some 🪶 "Widespread DNA off-targeting confounds studies of RNA chromatin occupancy" led by our @MicahGoldrich and Louis Delhaye from @pieter_mestdagh. TL;DR we show that many of lncRNA chromatin occupancy maps are flawed🧵biorxiv.org/content/10.110…

@UCLHresearchand & @uclcancer are recruiting an independent Research Fellow and Clinical Training Fellow. Research areas: Cancer Immunotherapy, Early Diagnosis, Tumour Heterogeneity and Targeted Therapy and Non-chemo Treatments ucl.ac.uk/work-at-ucl/se… ucl.ac.uk/work-at-ucl/se…

Interested in applying your molecular biology skills to improve tumour immunotherapy? @CRUKCOLcentre PhD studentship available in my lab @uclcancer in collaboration with @diunguyen_vn_uk @Bartscancer For more information and to apply: colcc.ac.uk/phd-studentshi…

Are you looking for a Clinical Research Training Fellowship? Do you want join our team working in cancer immunology and immunotherapy? Check this great opportunity from @CRUKCOLcentre colcc.ac.uk/clinical-resea…  and contact our team to discuss our proposed project

@quezada This work reveals mechanisms that regulate CD4+ TCTX function in tumours and highlights the potential therapeutic utility of targeting post-transcriptional regulatory pathways in T cells for the treatment of cancer. 8/8

@quezada Constitutive expression of Zfp36l1 in T cells nullified anti-tumour responses while knocking out Zfp36l1 and its paralogue Zfp36 released the block to GzmB protein production and promoted tumour control. 7/8

Pleased to share our preprint describing a central role for post-transcriptional processes in the response to cancer immunotherapy. Huge amount of work led by Maria Vila de Mucha and @julia_hlond in collaboration with @QuezadaLab and @MartT_babraham 1/8 biorxiv.org/content/10.110…

Delighted that our work on EZH2 dominant negativity in Weaver syndrome is now out in Genes & Development! This exciting work on chromatinopathies 🧬 was in collab with @adrianbracken and spearheaded by Orla Deevy. @ucddublin @UCD_SBBS @UCD_Conway ucd.ie/newsandopinion…

Many proteins bind RNA, yet we still don’t know what RNAs most bind because methods map one RBP at a time. In @CellCellPress, with the Jovanovic lab, we describe SPIDR – a method for mapping the RNA binding sites of dozens of RBPs in a single experiment. sciencedirect.com/science/articl…

We have put together great programme for our London mini RNA symposium “RNA in cancer” on 16th July. Hope to see many of RNA aficionados next week at @QMBCI